NCT03645187招募中4 期
Evaluation of Anticancer Effect of Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer
Sherief Abd-Elsalam1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年8月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- number of patients with improved radiology
研究概览
简要总结
The study aimed at evaluation of anticancer effect of celecoxib as adjuvant therapy to chemotherapy in patients with metastatic colorectal cancer
详细描述
The primary aim of the study is to evaluate the anticancer effect of celecoxib as adjuvant therapy to chemotherapy in patients with metastatic colorectal cancer
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •advanced colorectal cancer
排除标准
- •cerebral metastases
- •other malignancy
- •H pylori infection
- •thromboembolism
研究组 & 干预措施
FOLFERI
Active Comparator
FOLFERI regien
干预措施: FOLFERI (Drug)
FOLFERI and celecoxib
Active Comparator
FOLFERI and celecoxib
干预措施: Folferi and celecoxib (Drug)
结局指标
主要结局
number of patients with improved radiology
时间窗: 6 months
number of patients with improved radiology
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
PhDTropical Medicine
Tanta University
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast CancerBreast CancerNCT00135018Organisation for Oncology and Translational Research
已完成
2 期
Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By SurgeryColorectal CancerNCT00336960Vanderbilt-Ingram Cancer Center24
已完成
1 期
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder CancerBladder CancerNCT02885974Baylor College of Medicine22
终止
2 期
Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung CancerHead and Neck CancerLung CancerNCT00527982M.D. Anderson Cancer Center1
终止
2 期
Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung CancerLung CancerNCT00520845Vanderbilt-Ingram Cancer Center23